Stockscreener 앱 받기
1.265
2.02%
0.025
Cardiol Therapeutics Inc 주식(CRDL)의 최신 뉴스
Cetera Investment Advisers Takes $56,000 Position in Cardiol Therapeutics Inc. (NASDAQ:CRDL) - Defense World
Cardiol Therapeutics (NASDAQ:CRDL) Now Covered by Analysts at HC Wainwright - Defense World
This Visa Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Benzinga
HC Wainwright & Co. Initiates Coverage of Cardiol Therapeutics (CRDL) with Buy Recommendation - Nasdaq
Cardiol Therapeutics (CRDL): HC Wainwright & Co. Initiates Coverage with a Buy Rating and $9 Price Target | CRDL Stock News - GuruFocus
H.C. Wainwright Initiates Coverage on Cardiol Therapeutics (CRDL) With Positive Outlook | CRDL Stock News - GuruFocus
(CRDL) Strategic Investment Guide (CRDL:CA) - news.stocktradersdaily.com
(CRDL) Technical Pivots with Risk Controls (CRDL:CA) - news.stocktradersdaily.com
Cardiol Therapeutics Announces AGM Results and New Board Member - TipRanks
Cardiol Therapeutics Reports Results of 2025 Annual General Meeting of Shareholders | CRDL Stock News - GuruFocus
Cardiol Therapeutics Reports Results of 2025 Annual General Meeting of Shareholders - Newsfile
Ex-Eli Lilly Chief Medical Officer Strengthens Cardiol Board as Critical Phase III Trial Nears Completion - Stock Titan
Cardiol Therapeutics Reports Q1 2025 Financial Results - TipRanks
Cardiol Therapeutics to Webcast Virtual Annual General Meeting o - GuruFocus
(CRDL) Market Insights and Trading Signals (CRDL:CA) - news.stocktradersdaily.com
Cardiol Therapeutics Inc. - Baystreet.ca
Stocks In Play: Cardiol Therapeutics Inc. - Barchart.com
Cardiol Therapeutics to Webcast AGM Amidst Ongoing Clinical Trials - TipRanks
Cardiol Therapeutics to Webcast Virtual Annual General Meeting of Shareholders on May 28th at 4:30 p.m. EDT - Newsfile
Cardiol Therapeutics Announces Virtual AGM: How Shareholders Can Participate Online May 28 - Stock Titan
Cardiol Therapeutics (OTCMKTS:CRTPF) Stock Price Up 2.8% – Here’s Why - Defense World
(CRDL) Investment Performance Report (CRDL:CA) - news.stocktradersdaily.com
AMD Will Be as ‘Aggressive as Possible’ to Challenge Nvidia - The Globe and Mail
(CRDL) Stock Market Analysis (CRDL:CA) - news.stocktradersdaily.com
Cardiol Therapeutics (TSE:CRDL) Stock Price Down 5.2% – Time to Sell? - Defense World
(CRDL) Market Performance Analysis (CRDL:CA) - news.stocktradersdaily.com
(CRDL) Strategic Equity Report (CRDL:CA) - news.stocktradersdaily.com
Acceleration of RAD204 Phase 1 dose escalation trial - Investing News Network
(CRDL) Advanced Trading Insights (CRDL:CA) - news.stocktradersdaily.com
Cardiol Therapeutics Inc. (NASDAQ:CRDL) Given Consensus Rating of “Buy” by Analysts - Defense World
Envestnet Asset Management Inc. Makes New Investment in Cardiol Therapeutics Inc. (NASDAQ:CRDL) - Defense World
Lodgement of CONNEQT Pulse Device with the TGA - Investing News Network
(CRDL) Trading Performance and Risk Management (CRDL:CA) - news.stocktradersdaily.com
(CRDL) Daily Stock Insights (CRDL:CA) - news.stocktradersdaily.com
March Quarterly Activities Report - Investing News Network
March Quarterly Appendix 4C - Investing News Network
Cardiol Therapeutics (TSE:CRDL) Trading Up 6.7% – What’s Next? - Defense World
Profound Medical Corp. - Baystreet.ca
Stocks in play: Cardiol Therapeutics Inc. - The Globe and Mail
Cardiol Therapeutics Nominates Dr. Timothy Garnett to Its Board of Directors | CRDL Stock News - GuruFocus
Cardiol Therapeutics Nominates Dr. Timothy Garnett to Board Amid Phase III Trial Progress - TipRanks
The S&P 500 Is Doing Something That Hasn't Been Seen in Nearly 100 Years. Here Are the 10 Most Important Stocks to Keep an Eye On. - The Globe and Mail
Cardiol Therapeutics Nominates Dr. Timothy Garnett to Its Board of Directors - Newsfile
Cardiol Therapeutics announces annual shareholder meeting By Investing.com - Investing.com India
Cardiol Therapeutics announces annual shareholder meeting - Investing.com
Cardiol Therapeutics Schedules Virtual Annual General Meeting for May 2025 - TipRanks
First patient dosed in Phase IIb imaging for Brain Mets - Investing News Network
(CRDL) Strategic Market Analysis (CRDL:CA) - news.stocktradersdaily.com
A Heart Disease Cure For Pericarditis? Phase 3 Trial Advances | David ElsleyCardiol Therapeutics - thedeepdive.ca
Long Term Trading Analysis for (CRDL) (CRDL:CA) - news.stocktradersdaily.com
(CRDL) Risk-Controlled Trading Report (CRDL:CA) - news.stocktradersdaily.com
Cardiol Therapeutics Stock: Is Cannabis Potential Priced In? - Nasdaq
Genocea Biosciences (NASDAQ:GNCA) versus Cardiol Therapeutics (NASDAQ:CRDL) Head-To-Head Review - Defense World
(CRDL) Investment Analysis and Advice (CRDL:CA) - news.stocktradersdaily.com
Roth Capital Has Bearish Forecast for CRDL Q1 Earnings - Defense World
Cardiol Therapeutics (CRDL) Projected to Post Quarterly Earnings on Monday - Defense World
3.28%
2.99%
자본화:
|
볼륨(24시간):